The UK's burgeoning copyright movement is noticing a noticeable shift, expanding far outside the traditional focus on Acid and Psilocybin. Interest in profound substances like Dimethyltryptamine is increasing, and accompanied by the discovery of innovative cannabinoids, especially Cannabigerol and other CBD-related compounds, that provide unique th